Sp1 and Sp3 are involved in the full transcriptional activity of centromere protein H in human nasopharyngeal carcinoma cells

FEBS Journal

Volumn 279, Issue 15, 2012, Pages 2714-2726

  Zhao, Wei Feng ^a   Wang, Hong Bo ^a   Xie, Bo ^b   Hu, Li Juan ^a   Xu, Li Hua ^a   Kuang, Bo Hua ^a   Li, Man Zhi ^a   Zhang, Xing ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

centromere protein H (CENPH); nasopharyngeal carcinoma; Sp1; Sp3; transcriptional regulation

Indexed keywords

CENTROMERE PROTEIN H; DNA; MESSENGER RNA; MITHRAMYCIN; NUCLEAR PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL IMMORTALIZATION; CENPH GENE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA FLANKING REGION; EPITHELIUM CELL; GEL MOBILITY SHIFT ASSAY; GENE; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR CLONING; NASOPHARYNX CARCINOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; SITE DIRECTED MUTAGENESIS; TRANSACTIVATION; TRANSCRIPTION REGULATION; UPREGULATION;

BASE SEQUENCE; BINDING SITES; CELL LINE, TUMOR; CHROMOSOMAL PROTEINS, NON-HISTONE; CLONING, MOLECULAR; GENE KNOCKDOWN TECHNIQUES; HUMANS; MUTAGENESIS, SITE-DIRECTED; NASOPHARYNGEAL NEOPLASMS; PLICAMYCIN; PROMOTER REGIONS, GENETIC; RECOMBINANT PROTEINS; REGULATORY ELEMENTS, TRANSCRIPTIONAL; RNA, MESSENGER; RNA, NEOPLASM; RNA, SMALL INTERFERING; SP1 TRANSCRIPTION FACTOR; SP3 TRANSCRIPTION FACTOR;

EID: 84863846591     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2012.08654.x     Document Type: Article

References (46)

1. Sugata N, Munekata E, &, Todokoro K, (1999) Characterization of a novel kinetochore protein, CENP-H. J Biol Chem 274, 27343-27346.
2. Sugata N, Li S, Earnshaw WC, Yen TJ, Yoda K, Masumoto H, Munekata E, Warburton PE, &, Todokoro K, (2000) Human CENP-H multimers colocalize with CENP-A and CENP-C at active centromere-kinetochore complexes. Hum Mol Genet 9, 2919-2926.
3. Fukagawa T, Mikami Y, Nishihashi A, Regnier V, Haraguchi T, Hiraoka Y, Sugata N, Todokoro K, Brown W, &, Ikemura T, (2001) CENP-H, a constitutive centromere component, is required for centromere targeting of CENP-C in vertebrate cells. EMBO J 20, 4603-4617.
4. Westermann S, Cheeseman IM, Anderson S, Yates JR III, Drubin DG, &, Barnes G, (2003) Architecture of the budding yeast kinetochore reveals a conserved molecular core. J Cell Biol 163, 215-222.
5. Orthaus S, Ohndorf S, &, Diekmann S, (2006) RNAi knockdown of human kinetochore protein CENP-H. Biochem Biophys Res Commun 348, 36-46.
6. Izuta H, Ikeno M, Suzuki N, Tomonaga T, Nozaki N, Obuse C, Kisu Y, Goshima N, Nomura F, Nomura N, et al. (2006) Comprehensive analysis of the ICEN (Interphase Centromere Complex) components enriched in the CENP-A chromatin of human cells. Genes Cells 11, 673-684.
7. Zhao X, Zhao L, Tian T, Zhang Y, Tong J, Zheng X, &, Meng A, (2010) Interruption of cenph causes mitotic failure and embryonic death, and its haploinsufficiency suppresses cancer in zebrafish. J Biol Chem 285, 27924-27934.
8. Amaro AC, Samora CP, Holtackers R, Wang E, Kingston IJ, Alonso M, Lampson M, McAinsh AD, &, Meraldi P, (2010) Molecular control of kinetochore-microtubule dynamics and chromosome oscillations. Nat Cell Biol 12, 319-329.
9. Okada M, Cheeseman IM, Hori T, Okawa K, McLeod IX, Yates JR III, Desai A, &, Fukagawa T, (2006) The CENP-H-I complex is required for the efficient incorporation of newly synthesized CENP-A into centromeres. Nat Cell Biol 8, 446-457.
10. Kwon MS, Hori T, Okada M, &, Fukagawa T, (2007) CENP-C is involved in chromosome segregation, mitotic checkpoint function, and kinetochore assembly. Mol Biol Cell 18, 2155-2168.
11. Tomonaga T, Matsushita K, Ishibashi M, Nezu M, Shimada H, Ochiai T, Yoda K, &, Nomura F, (2005) Centromere protein H is up-regulated in primary human colorectal cancer and its overexpression induces aneuploidy. Cancer Res 65, 4683-4689.
12. Liao WT, Feng Y, Li ML, Liu GL, Li MZ, Zeng MS, &, Song LB, (2011) Overexpression of centromere protein H is significantly associated with breast cancer progression and overall patient survival. Chin J Cancer 30, 627-637.
13. Shigeishi H, Higashikawa K, Ono S, Mizuta K, Ninomiya Y, Yoneda S, Taki M, &, Kamata N, (2006) Increased expression of CENP-H gene in human oral squamous cell carcinomas harboring high-proliferative activity. Oncol Rep 16, 1071-1075.
14. Liao WT, Song LB, Zhang HZ, Zhang X, Zhang L, Liu WL, Feng Y, Guo BH, Mai HQ, Cao SM, et al. (2007) Centromere protein H is a novel prognostic marker for nasopharyngeal carcinoma progression and overall patient survival. Clin Cancer Res 13, 508-514.
15. Guo XZ, Zhang G, Wang JY, Liu WL, Wang F, Dong JQ, Xu LH, Cao JY, Song LB, &, Zeng MS, (2008) Prognostic relevance of centromere protein H expression in esophageal carcinoma. BMC Cancer 8, 233-245.
16. Liao WT, Wang X, Xu LH, Kong QL, Yu CP, Li MZ, Shi L, Zeng MS, &, Song LB, (2009) Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival. Cancer 115, 1507-1517.
17. Liao WT, Yu CP, Wu DH, Zhang L, Xu LH, Weng GX, Zeng MS, Song LB, &, Li JS, (2009) Upregulation of CENP-H in tongue cancer correlates with poor prognosis and progression. J Exp Clin Cancer Res 28, 74-81.
18. Davie JR, He S, Li L, Sekhavat A, Espino P, Drobic B, Dunn KL, Sun JM, Chen HY, Yu J, et al. (2008) Nuclear organization and chromatin dynamics-Sp1, Sp3 and histone deacetylases. Adv Enzyme Regul 48, 189-208.
19. Majello B, De Luca P, &, Lania L, (1997) Sp3 is a bifunctional transcription regulator with modular independent activation and repression domains. J Biol Chem 272, 4021-4026.
20. Yu B, Datta PK, &, Bagchi S, (2003) Stability of the Sp3-DNA complex is promoter-specific: Sp3 efficiently competes with Sp1 for binding to promoters containing multiple Sp-sites. Nucleic Acids Res 31, 5368-5376.
21. Wang XB, Peng WQ, Yi ZJ, Zhu SL, &, Gan QH, (2007) Expression and prognostic value of transcriptional factor sp1 in breast cancer. Ai Zheng 26, 996-1000.
22. Chuang JY, Wu CH, Lai MD, Chang WC, &, Hung JJ, (2009) Overexpression of Sp1 leads to p53-dependent apoptosis in cancer cells. Int J Cancer 125, 2066-2076.
23. Kong LM, Liao CG, Fei F, Guo X, Xing JL, &, Chen ZN, (2010) Transcription factor Sp1 regulates expression of cancer-associated molecule CD147 in human lung cancer. Cancer Sci 101, 1463-1470.
24. Xu HG, Jin R, Ren W, Zou L, Wang Y, &, Zhou GP, (2012) Transcription factors Sp1 and Sp3 regulate basal transcription of the human IRF-3 gene. Biochimie 94, 1390-1397.
25. Blume SW, Snyder RC, Ray R, Thomas S, Koller CA, &, Miller DM, (1991) Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo. J Clin Invest 88, 1613-1621.
26. Manning AL, Longworth MS, &, Dyson NJ, (2010) Loss of pRB causes centromere dysfunction and chromosomal instability. Genes Dev 24, 1364-1376.
27. Martinez AC, &, van Wely KH, (2011) Centromere fission, not telomere erosion, triggers chromosomal instability in human carcinomas. Carcinogenesis 32, 796-803.
28. Varmus HE, (1987) Oncogenes and transcriptional control. Science 238, 1337-1339.
29. Li B, Adams CC, &, Workman JL, (1994) Nucleosome binding by the constitutive transcription factor Sp1. J Biol Chem 269, 7756-7763.
30. Noti JD, (1997) Sp3 mediates transcriptional activation of the leukocyte integrin genes CD11C and CD11B and cooperates with c-Jun to activate CD11C. J Biol Chem 272, 24038-24045.
31. Black AR, Black JD, &, Azizkhan-Clifford J, (2001) Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol 188, 143-160.
32. Lee VH, Chow BK, Lo KW, Chow LS, Man C, Tsao SW, &, Lee LT, (2009) Regulation of RASSF1A in nasopharyngeal cells and its response to UV irradiation. Gene 443, 55-63.
33. Su B, Xiang B, Wang L, Cao L, Xiao L, Li X, Wu M, &, Li G, (2010) Profiling and comparing transcription factors activated in non-metastatic and metastatic nasopharyngeal carcinoma cells. J Cell Biochem 109, 173-183.
34. Ward SV, &, Samuel CE, (2003) The PKR kinase promoter binds both Sp1 and Sp3, but only Sp3 functions as part of the interferon-inducible complex with ISGF-3 proteins. Virology 313, 553-566.
35. Dokmanovic M, &, Marks PA, (2005) Prospects: histone deacetylase inhibitors. J Cell Biochem 96, 293-304.
36. Jaiswal AS, Balusu R, &, Narayan S, (2006) 7,12- Dimethylbenzanthracene-dependent transcriptional regulation of adenomatous polyposis coli (APC) gene expression in normal breast epithelial cells is mediated by GC-box binding protein Sp3. Carcinogenesis 27, 252-261.
37. Kimura N, Takamatsu N, Yaoita Y, &, Osamura RY, (2008) Identification of transcriptional regulatory elements in the human somatostatin receptor sst2 promoter and regions including estrogen response element half-site for estrogen activation. J Mol Endocrinol 40, 75-91.
38. Kim H, Lee S, Park B, &, Che L, (2010) Sp1 and Sp3 mediate basal and serum-induced expression of human CENP-W. Mol Biol Rep 37, 3593-3600.
39. Koller CA, &, Miller DM, (1986) Preliminary observations on the therapy of the myeloid blast phase of chronic granulocytic leukemia with plicamycin and hydroxyurea. N Engl J Med 315, 1433-1438.
40. Dutcher JP, Coletti D, Paietta E, &, Wiernik PH, (1997) A pilot study of alpha-interferon and plicamycin for accelerated phase of chronic myeloid leukemia. Leuk Res 21, 375-380.
41. Liang Y, Zhong Z, Huang Y, Deng W, Cao J, Tsao G, Liu Q, Pei D, Kang T, &, Zeng YX, (2010) Stem-like cancer cells are inducible by increasing genomic instability in cancer cells. J Biol Chem 285, 4931-4940.
42. Song LB, Zeng MS, Liao WT, Zhang L, Mo HY, Liu WL, Shao JY, Wu QL, Li MZ, Xia YF, et al. (2006) Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells. Cancer Res 66, 6225-6232.
43. Song LB, Liao WT, Mai HQ, Zhang HZ, Zhang L, Li MZ, Hou JH, Fu LW, Huang WL, Zeng YX, et al. (2006) The clinical significance of twist expression in nasopharyngeal carcinoma. Cancer Lett 242, 258-265.
44. Zeng M, Kumar A, Meng G, Gao Q, Dimri G, Wazer D, Band H, &, Band V, (2002) Human papilloma virus 16 E6 oncoprotein inhibits retinoic X receptor-mediated transactivation by targeting human ADA3 coactivator. J Biol Chem 277, 45611-45618.
45. Li M, Linseman DA, Allen MP, Meintzer MK, Wang X, Laessig T, Wierman ME, &, Heidenreich KA, (2001) Myocyte enhancer factor 2A and 2D undergo phosphorylation and caspase-mediated degradation during apoptosis of rat cerebellar granule neurons. J Neurosci 21, 6544-6552.
46. Yuan Z, Gong S, Luo J, Zheng Z, Song B, Ma S, Guo J, Hu C, Thiel G, Vinson C, et al. (2009) Opposing roles for ATF2 and c-Fos in c-Jun-mediated neuronal apoptosis. Mol Cell Biol 29, 2431-2442.